CD8A and neoplasm: By releasing cytokines such as IFN-γ, TNF, and IL-2, CD4+ T cells further promote the differentiation and activation of macrophages, CD8+ T cells, and NK cells, while limiting tumor-associated angiogenesis, thereby reinforcing antitumor responses [45].